The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Stop the Rheumatoid Arthritis (RA) Cascade Early

Stop the Rheumatoid Arthritis (RA) Cascade Early

May 1, 2008 • By Sue Pondrom

  • Tweet
  • Email
Print-Friendly Version / Save PDF

This is Part One of a two-part series on early arthritis clinics.

You Might Also Like
  • Rheumatoid Arthritis: Time Is of the Essence
  • Will New Rheumatoid Arthritis Blood Test Improve Early Diagnosis?
  • The Key to Early Rheumatoid Arthritis
Explore This Issue
May 2008
Also By This Author
  • BATTER-UP Takes Swing at Potential RA Biomarkers

Early arthritis clinics (EACs) and the huge research databases amassed over the past 20 to 30 years in Europe and other countries have vastly improved physicians’ understanding and treatment of the early stages of rheumatoid arthritis (RA).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The pioneering EACs, many of which are in Europe, were established by rheumatologists seeking an earlier intervention in RA. The EACs were largely responsible for current criteria used to predict persistent RA in early, undifferentiated arthritic patients, and for the advent of new treatments that enhance patient outcomes.

RA patients were first studied in the late 1950s with population-based studies in Bath, U.K., and in the 1960s from cohorts in Middlesex, U.K., and Memphis, Tenn. As a result, research published in the 1980s demonstrated early structural erosion and the long-term consequences of RA. At that time, treatment guidelines for the initial therapy of RA called for nonsteroidal anti-inflammatory drugs, with disease-modifying antirheumatic drugs (DMARDs) prescribed much later, often after early destruction had already occurred.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although today’s EACs vary in their definition of “early” RA (some restrict selection to patients symptomatic for three or less months, while others allow patients with symptoms for up to two years), they have universally adopted improved diagnostic and imaging techniques—and, most importantly, the use of DMARDs earlier in the course of disease.

Beginnings in Birmingham

One of the first EACs was founded in 1983 at Queen Elizabeth Hospital, Birmingham, U.K., by Paul Bacon, MD, at that time the Arthritis Research Campaign (ARC) professor of rheumatology at the University of Birmingham. His goal was to identify factors to predict which patients with early synovitis would go on to develop RA. The Birmingham clinic had ceased operation in the mid 1980s, but then Paul Emery, MD, arrived and restarted it. Dr. Emery is currently the ARC professor of rheumatology at the University of Leeds, U.K., and director of the Leeds EAC, which he formed in 1994.

The goals of the early EACs were important because “one would like to focus therapy on those patients who are going to develop RA while sparing the half of early arthritis patients who get better spontaneously from the risks of therapy,” says Karim Raza, MD, the current director of the Birmingham EAC, now located at City Hospital Birmingham. “Much of the work carried out in this early arthritis clinic was done in collaboration with Mike Salmon, PhD, and Dr. Emery, who made important contributions in the field of genetic predictors of disease outcome.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: clinic, diagnose, Diagnostic Criteria, Early arthritis clinics (EACs), outcome, Rheumatoid Arthritis (RA), TreatmentIssue: May 2008

You Might Also Like:
  • Rheumatoid Arthritis: Time Is of the Essence
  • Will New Rheumatoid Arthritis Blood Test Improve Early Diagnosis?
  • The Key to Early Rheumatoid Arthritis
  • Bronchial Tissue Immune Activation Seen in Early Rheumatoid Arthritis

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.